Nautilus Biotechnology
GenomeWeb Top 40 Falls 6 Percent in March, Tracking Decline in Broader Market
The Dow Jones Industrial Average fell 4 percent while the Nasdaq fell 8 percent and the Nasdaq Biotech Index declined by 6 percent.
Nautilus Biotech Pushes Launch Date for Proteome Platform to Late 2026, Cuts 16 Percent of Staff
Premium
The company said that this latest delay will provide it additional time needed to optimize elements of its platform surface chemistry and assay conditions.
People in the News at Seer, Quantum-Si, Nautilus Biotechnology, Bio-Techne, FYR Diagnostics
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
GenomeWeb Top 40 Falls 3 Percent in December Amid Mixed Broader Market
The Dow Jones Industrial Average fell 5 percent while the Nasdaq rose by less than 1 percent, and the Nasdaq Biotech Index dropped 7 percent.
While technology advances were perhaps less dramatic than in the year prior, several firms teased future releases that could have significant impacts.
Dec 4, 2024
Jul 30, 2024
Nautilus Biotechnology Posts $18M Net Loss in Q2
Apr 30, 2024
Nautilus Biotechnology Records $18.7M Net Loss in Q1
Jan 24, 2024